Search by Drug Name or NDC

    NDC 50458-0295-15 SPORANOX 10 mg/mL Details

    SPORANOX 10 mg/mL

    SPORANOX is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is ITRACONAZOLE.

    Product Information

    NDC 50458-0295
    Product ID 50458-295_091ec6b1-4ff4-6281-e063-6394a90a33b1
    Associated GPIs 11407035002020
    GCN Sequence Number 027465
    GCN Sequence Number Description itraconazole SOLUTION 10 MG/ML ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 49100
    HICL Sequence Number 006503
    HICL Sequence Number Description ITRACONAZOLE
    Brand/Generic Brand
    Proprietary Name SPORANOX
    Proprietary Name Suffix n/a
    Non-Proprietary Name itraconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name ITRACONAZOLE
    Labeler Name Janssen Pharmaceuticals, Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020657
    Listing Certified Through 2024-12-31

    Package

    NDC 50458-0295-15 (50458029515)

    NDC Package Code 50458-295-15
    Billing NDC 50458029515
    Package 150 mL in 1 BOTTLE (50458-295-15)
    Marketing Start Date 1997-02-21
    NDC Exclude Flag N
    Pricing Information N/A